• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一些 2-氧代吲哚啉衍生物的合成及抗癌活性作为潜在的 CDK2 抑制剂。

Synthesis and anticancer activity of some 2-oxindoline derivatives as potential CDK2 inhibitors.

机构信息

Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.

出版信息

J Biomol Struct Dyn. 2023;41(24):15009-15022. doi: 10.1080/07391102.2023.2187222. Epub 2023 Mar 16.

DOI:10.1080/07391102.2023.2187222
PMID:36927308
Abstract

Novel series of 2-oxindoline hydrazones , 3-hydroxy-2-oxoindolines and 2-oxoindolin-3-ylidenes were prepared and assessed for their anticancer activity towards breast cancer cell line (MCF7). Compounds , , , , and (IC = 14.0 ± 0.7, 15.6 ± 0.7, 13.8 ± 0.7, 4.9 ± 0.2, 6.0 ± 0.3 and 10.8 ± 0.5 µM, respectively) showed the highest growth inhibition activity against MCF7 when compared to staurosporine (IC = 14.5 ± 0.7 µM). Cell cycle analysis exposed arrest at G1 phase for compounds , and , at S phase for compounds and , and at G1/S phase for compound . Apoptotic effect of compounds , , , , and was confirmed their early and late apoptotic effects. A safety profile was revealed for compounds , , , , and on MCF10A treated normal cell. Also, compounds and displayed a promising CDK2 inhibition activity (IC = 0.22 ± 0.01, 0.25 ± 0.01 µM, respectively). Also, docking study revealed comparable interactions with the native ligand (5-bromoindirubin). ADMET computational studies forecast the promising pharmacokinetic profile of the targeted compounds.Communicated by Ramaswamy H. Sarma.

摘要

新型 2-氧代吲哚啉腙、3-羟基-2-氧代吲哚啉和 2-氧代吲哚啉-3-亚烯类化合物被制备出来,并评估了它们对乳腺癌细胞系(MCF7)的抗癌活性。与 staurosporine(IC=14.5±0.7µM)相比,化合物 、 、 、 、 和 (IC=14.0±0.7、15.6±0.7、13.8±0.7、4.9±0.2、6.0±0.3 和 10.8±0.5µM)对 MCF7 的生长抑制活性最高。细胞周期分析表明,化合物 、 和 使细胞停滞在 G1 期,化合物 、 和 使细胞停滞在 S 期,化合物 使细胞停滞在 G1/S 期。化合物 、 、 、 、 和 的凋亡作用证实了它们具有早期和晚期凋亡作用。在 MCF10A 处理的正常细胞上,化合物 、 、 、 、 和 显示出良好的安全性特征。此外,化合物 、 和 显示出有希望的 CDK2 抑制活性(IC=0.22±0.01、0.25±0.01µM)。对接研究还表明,这些化合物与天然配体(5-溴靛红)具有类似的相互作用。ADMET 计算研究预测了靶向化合物有希望的药代动力学特征。

相似文献

1
Synthesis and anticancer activity of some 2-oxindoline derivatives as potential CDK2 inhibitors.一些 2-氧代吲哚啉衍生物的合成及抗癌活性作为潜在的 CDK2 抑制剂。
J Biomol Struct Dyn. 2023;41(24):15009-15022. doi: 10.1080/07391102.2023.2187222. Epub 2023 Mar 16.
2
Examining the 2-aryl-5-nitrobenzofuran-based hydrazones for anti-breast (MCF-7) cancer activity, potential to induce cell cycle arrest and inhibit receptor tyrosine kinases (VEGFR-2 & EGFR).研究基于2-芳基-5-硝基苯并呋喃的腙类化合物的抗乳腺癌(MCF-7)活性、诱导细胞周期停滞的潜力以及抑制受体酪氨酸激酶(VEGFR-2和EGFR)的能力。
Eur J Med Chem. 2025 Nov 15;298:118018. doi: 10.1016/j.ejmech.2025.118018. Epub 2025 Aug 4.
3
Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies.新型苯磺酰胺类双重 VEGFR2/FGFR1 抑制剂靶向治疗乳腺癌:设计、合成、抗癌活性及计算机模拟研究。
Bioorg Chem. 2024 Nov;152:107728. doi: 10.1016/j.bioorg.2024.107728. Epub 2024 Aug 17.
4
Integrated structure- and ligand-based design, synthesis, and biological evaluation of potent thiazole-based multi-kinase PI3Kα and CDK2/8 inhibitors as anticancer agents.基于结构和配体的强效噻唑基多激酶PI3Kα和CDK2/8抑制剂作为抗癌剂的整合设计、合成及生物学评价
Eur J Med Chem. 2025 Oct 15;296:117902. doi: 10.1016/j.ejmech.2025.117902. Epub 2025 Jun 24.
5
Design, synthesis, and anticancer evaluation of new pyrazolo[3,4-d]pyrimidine-based derivatives: CDK2 inhibition, apoptosis-inducing activity, molecular modelling studies.新型吡唑并[3,4-d]嘧啶类衍生物的设计、合成及抗癌评价:CDK2抑制、凋亡诱导活性及分子模拟研究
Bioorg Med Chem. 2025 Oct 1;128:118286. doi: 10.1016/j.bmc.2025.118286. Epub 2025 Jun 14.
6
Synthesis of S-alkylated oxadiazole bearing imidazo[2,1-b]thiazole derivatives targeting breast cancer: In vitro cytotoxic evaluation and in vivo radioactive tracing studies.靶向乳腺癌的含咪唑并[2,1-b]噻唑衍生物的S-烷基化恶二唑的合成:体外细胞毒性评估和体内放射性示踪研究。
Bioorg Chem. 2024 Dec;153:107935. doi: 10.1016/j.bioorg.2024.107935. Epub 2024 Nov 2.
7
Thieno[2,3-d]pyrimidine derivatives as topoisomerase II inhibitors: design, synthesis, anticancer evaluation, and in silico studies.噻吩并[2,3-d]嘧啶衍生物作为拓扑异构酶II抑制剂:设计、合成、抗癌评估及计算机模拟研究
Bioorg Chem. 2025 Sep;164:108839. doi: 10.1016/j.bioorg.2025.108839. Epub 2025 Aug 6.
8
Synthesis and apoptotic induction of sulfonamide-based chalcone hybrids as first-in-class dual histone deacetylase‑carbonic anhydrase inhibitors with potential anti-tubulin activity.基于磺胺的查耳酮杂化物的合成及其凋亡诱导作用,作为具有潜在抗微管蛋白活性的一流双组蛋白脱乙酰酶-碳酸酐酶抑制剂。
Bioorg Chem. 2025 Jun 20;163:108694. doi: 10.1016/j.bioorg.2025.108694.
9
Achillea fragrantissima (Forssk.) Sch. Bip. essential oil inhibits the growth of pancreatic cancer cells via induction of necrosis, sub-G1 arrest, modulation of β-catenin/ERK signalling pathways and p38α MAPK, CDK2, EGFR inhibition.香叶蓍(Achillea fragrantissima (Forssk.) Sch. Bip.)精油通过诱导坏死、亚G1期阻滞、调节β-连环蛋白/ERK信号通路以及抑制p38α丝裂原活化蛋白激酶、细胞周期蛋白依赖性激酶2(CDK2)和表皮生长因子受体(EGFR)来抑制胰腺癌细胞的生长。
J Ethnopharmacol. 2025 Jun 24;352:120201. doi: 10.1016/j.jep.2025.120201.
10
Discovery of Furopyrimidine-Pyrazole Hybrid Compounds Targeting p53-MDM2 Interaction as Anticancer Agents.
Arch Pharm (Weinheim). 2025 Sep;358(9):e70085. doi: 10.1002/ardp.70085.

引用本文的文献

1
Molecular Engineering of Bacterioferritin: A Versatile Nanodimensional Protein Cage.细菌血晶蛋白的分子工程:一种多功能的纳米级蛋白质笼。
Molecules. 2023 Jun 9;28(12):4663. doi: 10.3390/molecules28124663.